Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus

Virology Journal

Volumn 9, Issue , 2012, Pages

  Xue, Mei ^a   Wang, Haiwei ^a   Li, Wan ^a   Zhou, Guohui ^a   Tu, Yabin ^a   Yu, Li ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Antigenic variation; Foot and mouth disease virus; Replication ability; Virulence; VP2

Indexed keywords

ASPARAGINE; ASPARTIC ACID; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1B4; NEUTRALIZING ANTIBODY; PROTEIN VP2; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; ASIA1 FOOT AND MOUTH DISEASE VIRUS; COMPARATIVE STUDY; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; REVERSE GENETICS; SEROTYPE; SITE DIRECTED MUTAGENESIS; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID PROTEINS; FEMALE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; SEQUENCE ALIGNMENT; VIRULENCE;

FOOT-AND-MOUTH DISEASE VIRUS; MUS;

EID: 84865858979     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-191     Document Type: Article

References (32)

1. Foot-and-Mouth Disease. Grubman MJ, Baxt B, Clin Microbiol Rev 2004 17 465 493 10.1128/CMR.17.2.465-493.2004 15084510 (Pubitemid 38534037)
2. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Belsham GJ, Prog Biophys Mol Biol 1993 60 241 260 10.1016/0079-6107(93)90016-D 8396787
3. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Sobrino F, Palma EL, Beck E, Davila M, de la Torre JC, Negro P, Villanueva N, Ortin J, Domingo E, Gene 1986 50 149 159 10.1016/0378-1119(86)90320-3 3034729 (Pubitemid 17041747)
4. Genetic and antigenic variance of foot-and-mouth disease virus type Asia1. Marquardt O, Rahman MM, Freiberg B, Arch Virol 2000 145 149 157 10.1007/s007050050011 10664412 (Pubitemid 30095981)
5. Evolution of foot-and-mouth disease virus. Domingo E, Escarmis C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Nunez JI, Sobrino F, Virus Res 2003 91 47 63 10.1016/S0168-1702(02)00259-9 12527437 (Pubitemid 36078430)
6. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Borrego B, Camarero JA, Mateu MG, Domingo E, Viral Immunol 1995 8 11 18 10.1089/vim.1995.8.11 8546800
7. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E, Virology 1995 206 298 306 10.1016/S0042-6822(95)80045-X 7831785
8. Analysis of neutralizing epitopes on foot-and-mouth disease virus. Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H, J Virol 1988 62 2033 2040 2835507
9. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. Feigelstock D, Mateu MG, Piccone ME, De Simone F, Brocchi E, Domingo E, Palma EL, J Gen Virol 1992 73 Pt 12 3307 3311 1335031 (Pubitemid 23014189)
10. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR, J Gen Virol 1989 70 Pt 6 1483 1491 2471811 (Pubitemid 19165609)
11. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM, J Virol 1991 65 2518 2524 1707983
12. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. Mateu MG, Hernandez J, Martinez MA, Feigelstock D, Lea S, Perez JJ, Giralt E, Stuart D, Palma EL, Domingo E, J Virol 1994 68 1407 1417 8107204 (Pubitemid 24065702)
13. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F, Nature 1989 337 709 716 10.1038/337709a0 2537470 (Pubitemid 19064726)
14. Host cell selection of antigenic variants of foot-and-mouth disease virus. Bolwell C, Brown AL, Barnett PV, Campbell RO, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ, J Gen Virol 1989 70 Pt 1 45 57 2471782
15. Multiple origins of foot-and-mouth disease virus serotype Asia 1 outbreaks, 2003-2007. Valarcher JF, Knowles NJ, Zakharov V, Scherbakov A, Zhang Z, Shang YJ, Liu ZX, Liu XT, Sanyal A, Hemadri D, et al. Emerg Infect Dis 2009 15 1046 1051 10.3201/eid1507.081621 19624919
16. Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus. Du J, Chang H, Cong G, Shao J, Lin T, Shang Y, Liu Z, Liu X, Cai X, Xie Q, Virus Genes 2007 35 635 642 10.1007/s11262-007-0126- 8 17619135 (Pubitemid 350012762)
17. Recent spread of FMD virus serotype Asia 1. Valarcher JF, Knowles NJ, Ferris NP, Paton DJ, Zakharov V, Sherbakov A, Shang YJ, Liu ZX, Liu XT, Sanyal A, et al. Vet Rec 2005 157 30 15995241 (Pubitemid 40975674)
18. Recent Outbreaks of Foot-and-Mouth Disease Type Asia 1 in China. Guo H, Liu X, Liu Z, Yin H, Ma J, Wang Y, Shang Y, Zhang Q, Li D, Guo J, et al. J Vet Med B Infect Dis Vet Public Health 2006 53 29 33 10.1111/j.1439-0450.2006.01018. x 17123364 (Pubitemid 44748215)
19. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N, J Biol Chem 2004 279 47212 47221 10.1074/jbc.M405465200 15294895 (Pubitemid 39518378)
20. Mutation rates among RNA viruses. Drake JW, Holland JJ, Proc Natl Acad Sci U S A 1999 96 13910 13913 10.1073/pnas.96.24.13910 10570172
21. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, J Gen Virol 1989 70 Pt 6 1493 1503 2471812 (Pubitemid 19165610)
22. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus. Moore DM, Vakharia VN, Morgan DO, Virus Res 1989 14 281 295 10.1016/0168-1702(89)90022-1 2483013 (Pubitemid 20014457)
23. Antigenic sites on foot-and-mouth disease virus type A10. Thomas AA, Woortmeijer RJ, Puijk W, Barteling SJ, J Virol 1988 62 2782 2789 2455819
24. Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. Freiberg B, Hohlich B, Haas B, Saalmuller A, Pfaff E, Marquardt O, J Virol Methods 2001 92 199 205 10.1016/S0166-0934(00)00287-1 11226567 (Pubitemid 32171988)
25. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN, Parkhouse RM, J Gen Virol 1998 79 Pt 7 1687 1697 9680132 (Pubitemid 28330673)
26. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D, Structure 1996 4 135 145 10.1016/S0969-2126(96)00017-2 8805520 (Pubitemid 126658977)
27. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F, J Gen Virol 1989 70 Pt 3 625 637 2543752
28. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Baxt B, Becker Y, Virus Genes 1990 4 73 83 10.1007/BF00308567 2168107 (Pubitemid 20371782)
29. Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China. Zhang Q, Li D, Liu X, Liu Z, Cai X, Wu G, Qi S, Yang S, Yan X, Shang Y, et al. Res Vet Sci 2008 85 368 371 10.1016/j.rvsc.2007.11.005 18155114
30. Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody. Wang H, Zhao L, Li W, Zhou G, Yu L, Vet Microbiol 2011 148 189 199 10.1016/j.vetmic.2010.09.013 20961714
31. Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Yu L, J Microbiol 2011 49 94 101 10.1007/s12275-011-0134-1 21369985
32. Modification of a PCR-based site-directed mutagenesis method. Fisher CL, Pei GK, Biotechniques 1997 23 570 574 9343663 (Pubitemid 27450899)